Industry Roundup
This article was originally published in The Tan Sheet
Executive Summary
FDA warns eye supplement marketer; Kentucky age-restricts OTC DXM sales; FDA, EPA data-sharing pact; Colorado, Maine pass microbead laws; and more news in brief.
You may also be interested in...
Trade Groups Expand Caffeine Labeling To Stave Off Tighter Regs
The Council for Responsible Nutrition and the American Herbal Products Association amend guidelines and requirements for labeling and marketing caffeine-containing products, going beyond the law in response to congressional and public health complaints about the ingredient’s safety.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.